reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Nutex Health Inc.

NUTX · Nasdaq

1 reporting failure in the last 12 months

Companies at this level ended the following year delisted, bankrupt, restated or silent 9.2% of the time, against 4.0% for companies with a clean record.

$524Mpublic float
2025-11-17most recent failure
2025-08-21declared past accounts unreliable

Score over time

024202220232024202520262022-01-01 · score 32021-05-17 filed late (10-Q) · accounts not ready2021-04-01 filed late (10-K) · accounts not ready2021-03-05 auditor change2022-04-01 · score 22021-05-17 filed late (10-Q) · accounts not ready2021-04-01 filed late (10-K) · accounts not ready2022-10-01 · score 12022-08-15 filed late (10-Q) · acquisition or merger2023-01-01 · score 22022-11-15 filed late (10-Q) · accounts not ready2022-08-15 filed late (10-Q) · acquisition or merger2023-04-01 · score 32023-03-02 filed late (10-K) · acquisition or merger2022-11-15 filed late (10-Q) · accounts not ready2022-08-15 filed late (10-Q) · acquisition or merger2023-07-01 · score 42023-05-11 filed late (10-Q) · accounts not ready2023-03-02 filed late (10-K) · acquisition or merger2022-11-15 filed late (10-Q) · accounts not ready2022-08-15 filed late (10-Q) · acquisition or merger2023-10-01 · score 32023-05-11 filed late (10-Q) · accounts not ready2023-03-02 filed late (10-K) · acquisition or merger2022-11-15 filed late (10-Q) · accounts not ready2024-01-01 · score 22023-05-11 filed late (10-Q) · accounts not ready2023-03-02 filed late (10-K) · acquisition or merger2024-04-01 · score 22024-03-15 filed late (10-K) · auditor2023-05-11 filed late (10-Q) · accounts not ready2024-07-01 · score 12024-03-15 filed late (10-K) · auditor2024-10-01 · score 12024-03-15 filed late (10-K) · auditor2025-01-01 · score 12024-03-15 filed late (10-K) · auditor2025-07-01 · score 22025-05-21 auditor change2025-04-25 auditor change2025-10-01 · score 42025-08-21 accounts unreliable2025-08-14 filed late (10-Q) · accounts not ready2025-05-21 auditor change2025-04-25 auditor change2026-01-01 · score 52025-11-17 filed late (10-Q) · restatement2025-08-21 accounts unreliable2025-08-14 filed late (10-Q) · accounts not ready2025-05-21 auditor change2025-04-25 auditor change2026-04-01 · score 52025-11-17 filed late (10-Q) · restatement2025-08-21 accounts unreliable2025-08-14 filed late (10-Q) · accounts not ready2025-05-21 auditor change2025-04-25 auditor change2026-07-01 · score 32025-11-17 filed late (10-Q) · restatement2025-08-21 accounts unreliable2025-08-14 filed late (10-Q) · accounts not ready2026-10-01 · score 12025-11-17 filed late (10-Q) · restatement

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Nutex Health Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the period ended September 30, 2025 (the “Form 10-Q”) within the prescribed time period. As previously disclosed, the Company determined that it is necessary to restate certain previously issued financial statements, including its Annual Report on Form 10-K for the year ended December 31, 2024, and its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (collectively, the “Restated Filings”). The Company must complete and file these Restated Filings prior to filing the Form 10-Q for the quarter ended June 30, 2025. As a result, the Company’s finance and accounting teams require additional time to complete the preparation of the Form 10-Q for the quarter ended September 30, 2025. On August 20, 2025, the Company received a notice from The Nasdaq Stock Market LLC (the “Nasdaq Notice”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the "June 30, 2025 Form 10-Q”) with the Securities and Exchange Commission (the "SEC”). On October 15, 2025, in response to the Notice, the Company submitted to Nasdaq a plan to regain compliance with the Rule and requested an extension from the due date of its delinquent June 30, 2025 Form 10-Q until December 12, 2025, which was granted by Nasdaq on October 16, 2025. In the event the Company is not able to file the June 30, 2025 Form 10-Q with the SEC on or before December 12, 2025, the staff of Nasdaq will issue a delisting notice, which the Company may appeal to a Nasdaq Hearings Panel

NT 10-Q, filed 2025-11-17 · restatement

What it filed

2025-11-17filed late (10-Q)restatement SEC →

Nutex Health Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the period ended September 30, 2025 (the “Form 10-Q”) within the prescribed time period. As previously disclosed, the Company determined that it is necessary to restate certain previously issued financial statements, including its Annual Report on Form 10-K for the year ended December 31, 2024, and its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (collectively, the “Restated Filings”). The Company must complete and file these Restated Filings prior to filing the Form 10-Q for the quarter ended June 30, 2025. As a result, the Company’s finance and accounting teams require additional time to complete the preparation of the Form 10-Q for the quarter ended September 30, 2025. On August 20, 2025, the Company received a notice from The Nasdaq Stock Market LLC (the “Nasdaq Notice”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the "June 30, 2025 Form 10-Q”) with the Securities and Exchange Commission (the "SEC”). On October 15, 2025, in response to the Notice, the Company submitted to Nasdaq a plan to regain compliance with the Rule and requested an extension from the due date of its delinquent June 30, 2025 Form 10-Q until December 12, 2025, which was granted by Nasdaq on October 16, 2025. In the event the Company is not able to file the June 30, 2025 Form 10-Q with the SEC on or before December 12, 2025, the staff of Nasdaq will issue a delisting notice, which the Company may appeal to a Nasdaq Hearings Panel

2025-08-21accounts declared unreliable SEC →

2025-08-14filed late (10-Q)accounts not ready SEC →

Nutex Health Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the “Form 10-Q”) within the prescribed time period due to additional time needed to analyze classification of certain equity instruments and finalize its financial statements. The Company has dedicated significant resources to completing the Form 10-Q and is working diligently to complete the review. The registrant expects to file the Form 10-Q within the five-calendar day extension period provided by Rule 12b-25

2025-05-21auditor changed or resigned SEC →

2025-04-25auditor changed or resigned SEC →

2024-03-15filed late (10-K)auditor SEC →

Nutex Health Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”) within the prescribed time period due to delays in completion of the financial statements for the fiscal year ended December 31, 2023. ​ ‎The Form 10-K cannot be filed within the prescribed time period because the Company’s auditor requires additional time to review and finalize its audit of the Company’s financial statements to ensure adequate disclosure of the financial information required to be included in the Form 10-K. The Company has dedicated significant resources to completing the Form 10-K and is working diligently with the auditor to complete the necessary work to file the Form 10-K as soon as practicable within the 15th calendar day following the prescribed due date. ​

2023-05-11filed late (10-Q)accounts not ready SEC →

Nutex Health Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 (the “Form 10-Q”) within the prescribed time period due to delays in completion of the financial statements for the quarterly period ended March 31, 2023. ​ The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 cannot be filed within the prescribed time period because the Company requires additional time to review and finalize its consolidated financial statements to ensure adequate disclosure of the financial information required to be included in the Form 10-Q. The Company has dedicated significant resources to completing the Form 10-Q and is working diligently to complete the necessary work to file the Form 10-Q as soon as practicable within the 5th calendar day following the prescribed due date. ​

2023-03-02filed late (10-K)acquisition or merger SEC →

Nutex Health Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”) within the prescribed time period due to delays in completion of the financial statements for the fiscal year ended December 31, 2022. ​ ‎The Form 10-K cannot be filed within the prescribed time period because the Company require additional time to review and finalize its audited financial statements to ensure adequate disclosure of the financial information required to be included in the Form 10-K , including a revision to the valuation of warrants and options that were part of the merger consideration in the reverse merger (the “Merger”) of Clinigence Holdings Inc. (n/k/a Nutex Health Inc.) and Nutex Health Holdco LLC. The Company has dedicated significant resources to completing the Form 10-K and is working diligently to complete the necessary work to file the Form 10-K as soon as practicable within the 15th calendar day following the prescribed due date. ​

2022-11-15filed late (10-Q)accounts not ready SEC →

Nutex Health Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 (the “Form 10-Q”) within the prescribed time period due to delays in completion of the financial statements for the quarterly period ended September 30, 2022. The Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 cannot be filed within the prescribed time period because the Company requires additional time to review and finalize its consolidated financial statements to ensure adequate disclosure of the financial information required to be included in the Form 10-Q. The Company has dedicated significant resources to completing the Form 10-Q and is working diligently to complete the necessary work to file the Form 10-Q as soon as practicable within the 5th calendar day following the prescribed due date

2022-08-15filed late (10-Q)acquisition or merger SEC →

Nutex Health Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022 (the “Form 10-Q”) within the prescribed time period due to delays in completion of the financial statements for the quarterly period ended June 30, 2022. Effective April 1, 2022, the Company completed its Merger with Clinigence Holdings, Inc. and is preparing its first consolidated financial statements as a publicly traded Company during the quarterly period ended June 30, 2022‎. The Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 cannot be filed within the prescribed time period because the Company requires additional time to review and finalize its consolidated financial statements to ensure adequate disclosure of the financial information required to be included in the Form 10-Q. The Company has dedicated significant resources to completing the Form 10-Q and is working diligently to complete the necessary work to file the Form10-Q as soon as practicable within the 5th calendar day following the prescribed due date

2021-05-17filed late (10-Q)accounts not ready SEC →

The Registrant requires additional time to complete the final review of certain technical financial information related to various recent events impacting the Registrant and is not able to complete the preparation, review and filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The Company intends to file its Form 10-Q on or before May 24, 2021, the prescribed due date pursuant to this Form 12b-25

2021-04-01filed late (10-K)accounts not ready SEC →

The Registrant requires additional time to complete the final review of certain technical financial information related to various recent events impacting the Registrant and is not able to complete the preparation, review and filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense. The Company intends to file its Form 10-K on or before April 15, 2021, the prescribed due date pursuant to this Form 12b-25

2021-03-05auditor changed or resigned SEC →

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com